Lightship Partners with Castor to Scale Virtual Trials

Published on: 

Lightship and Castor have announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale.

For decades, clinical trials have experienced low rates of participation relative to the distribution of a condition, which can impact the ability to access diverse patient populations and construct a representative sample. One of the main reasons for this is the high burden of participation that patients often experience. Lightship’s delivery model combined with an in-house care team will provide the patient experience in clinical trials partnering with Castor’s globally compliant Decentralized Clinical Trial and Clinical Data Management platform.


For more information, click here.